Background pattern

BRIVIACT 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION

Ask a doctor about a prescription for BRIVIACT 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use BRIVIACT 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION

Introduction

Package Leaflet: Information for the Patient

Briviact 10 mg/ml Solution for Injection and Infusion

brivaracetam

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

Keep this leaflet. You may need to read it again.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
    • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Briviact and what is it used for
  2. What you need to know before you use Briviact
  3. How to use Briviact
  4. Possible side effects
  5. Storage of Briviact
  6. Contents of the pack and other information

1. What is Briviact and what is it used for

What is Briviact

Briviact contains the active substance brivaracetam. It belongs to a group of medicines called “antiepileptics”. These medicines are used to treat epilepsy.

What is Briviact used for

  • Briviact is used in adults, adolescents, and children from 2 years of age.
  • It is used to treat a type of epilepsy that causes partial seizures with or without secondary generalization.
  • Partial seizures are seizures that start by affecting only one side of the brain. These partial seizures can spread to larger areas of both sides of the brain – this is called “secondary generalization”.
  • Your doctor has prescribed this medicine to reduce the number of seizures you have.
  • Briviact is used together with other medicines to treat epilepsy.

2. What you need to know before you use Briviact

Do not use Briviact

  • if you are allergic to brivaracetam, to other similar chemical compounds such as levetiracetam or piracetam, or to any of the other ingredients of this medicine (listed in section 6). If you are not sure, consult your doctor or pharmacist before using Briviact.

Warnings and precautions

Talk to your doctor or pharmacist before starting Briviact:

  • If you have had thoughts of harming yourself or committing suicide. A small number of people taking antiepileptic medicines like Briviact have had thoughts of harming themselves or committing suicide. If you have any of these thoughts, contact your doctor immediately.
  • If you have liver problems, your doctor may need to adjust your dose.

Children

Do not give Briviact to children under 2 years of age.

Using Briviact with other medicines

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

In particular, tell your doctor if you are taking any of the following medicines, as your doctor may need to adjust your dose of Briviact:

  • Rifampicin, a medicine used to treat bacterial infections.
  • St. John's Wort (also known as Hypericum perforatum), a herbal medicine used to treat depression and anxiety, as well as other conditions.

Using Briviact with alcohol

It is not recommended to use this medicine with alcohol.

  • If you drink alcohol while taking Briviact, the negative effects of alcohol may increase.

Pregnancy and breastfeeding

Women of childbearing age should discuss the use of contraceptives with their doctor.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

It is not recommended to use Briviact if you are pregnant or breastfeeding, as the effects of Briviact on pregnancy and the fetus are unknown.

It is not recommended to breastfeed while taking Briviact, as Briviact is excreted in breast milk.

Do not stop treatment without consulting your doctor first. Stopping treatment may increase the number of seizures you have and harm your baby.

Driving and using machines

  • You may feel drowsy, dizzy, or tired while using Briviact.
  • These effects are more common at the start of treatment or after a dose increase.
  • Do not drive, ride a bike, or use any tools or machinery until you know how this medicine affects you.

Briviact contains sodium

This medicine contains 19.1 mg of sodium (the main component of table/cooking salt) per vial. This is equivalent to 1% of the maximum recommended daily sodium intake for an adult.

3. How to use Briviact

Follow the instructions for administration of this medicine exactly as told by your doctor. If you are unsure, consult your doctor or pharmacist again.

You will use Briviact together with other medicines to treat epilepsy.

  • When you start using this medicine, you will take Briviact orally (as tablets or oral solution) or it will be administered as an injection or infusion.
  • Briviact solution for injection and infusion is used for a short period of time while you cannot take Briviact orally.
  • You can switch from oral Briviact to the solution for injection and infusion, and vice versa.

Dose

Your doctor will calculate the correct daily dose for you. Take the daily dose in two equal doses, with an interval of approximately 12 hours.

Adolescents and children weighing 50 kg or more, and adults

  • The recommended dose is between 25 mg and 100 mg twice a day. Your doctor may later decide to adjust it to find the best dose for you.

Adolescents and children weighing from 20 kg to less than 50 kg

  • The recommended dose is between 0.5 mg and 2 mg per kg of body weight twice a day. Your doctor may later decide to adjust it to find the best dose for you.
  • The doses given in the following table are only examples. Your doctor will calculate the correct dose for you based on your weight.

Children weighing from 10 kg to less than 20 kg

  • Your child's doctor may prescribe the injection for only a few days if your child cannot take the medicine orally.
  • The recommended dose is 0.5 mg to 2.5 mg per kg of body weight, twice a day. Your child's doctor may then decide to adjust the dose to find the best dose for your child.

Patient with liver problems

If you have liver problems:

  • As an adolescent or child weighing 50 kg or more, or as an adult, the maximum dose you will take is 75 mg twice a day.
  • As an adolescent or child weighing from 20 kg to less than 50 kg, the maximum dose you will take is 1.5 mg per kg of body weight twice a day.
  • As a child weighing from 10 kg to less than 20 kg, the maximum dose your child will take is 2 mg per kg of body weight twice a day.

How to use Briviact

Briviact is administered by a doctor or nurse as an injection or infusion. This medicine is injected slowly into your vein or administered as an infusion (drip) over 15 minutes.

Duration of treatment with Briviact

  • Your doctor will decide how many days you should be given the injections or infusion.
  • For long-term treatment with Briviact, your doctor will ask you to take Briviact tablets or oral solution.

If you use more Briviact than you should

If you think you have been given too much Briviact, consult your doctor immediately.

If you stop treatment with Briviact

  • Do not stop treatment with this medicine unless your doctor tells you to. This is because stopping treatment may increase the number of seizures you have.
  • If your doctor decides to stop your treatment, he/she will give you instructions for gradual withdrawal of Briviact. This will help prevent your seizures from coming back or getting worse.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Very common:may affect more than 1 in 10 people.

  • drowsiness or dizziness

Common:may affect up to 1 in 10 people.

  • flu
  • feeling very tired (fatigue)
  • seizure, feeling of spinning (vertigo)
  • feeling sick and vomiting, constipation
  • pain or discomfort at the injection site
  • depression, anxiety, difficulty sleeping (insomnia), irritability
  • infections of the nose and throat (such as the “common cold”), cough
  • decreased appetite

Uncommon:may affect up to 1 in 100 people

  • allergic reactions
  • abnormal thoughts and/or loss of contact with reality (psychotic disorder), aggression, restlessness (agitation)
  • thoughts or attempts to harm yourself or commit suicide: tell your doctor immediately
  • a decrease in white blood cells (called “neutropenia”) – which appears in blood tests

Other side effects in children

Common:may affect up to 1 in 10 people

  • restlessness and hyperactivity (psychomotor hyperactivity)

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Briviact

  • Keep this medicine out of the sight and reach of children.
  • Do not use this medicine after the expiry date which is stated on the carton after CAD and on the vial after EXP. The expiry date is the last day of the month shown.
  • Briviact may be diluted before injection by your doctor or nurse. In such cases, it should be used immediately after dilution.
  • This medicine does not require any special storage conditions.
  • Each vial of Briviact solution for injection and infusion is for single use only. The unused solution should be discarded.
  • Only the clear, particle-free, and colorless solution should be used.
  • Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

Composition of Briviact

The active substance is brivaracetam.

  • Each ml contains 10 mg of brivaracetam.
  • Each 5 ml vial contains 50 mg of brivaracetam.

The other ingredients are: sodium acetate (trihydrate), glacial acetic acid, sodium chloride, water for injections.

Appearance of the product and pack size

Briviact 10 mg/ml solution for injection and infusion is a clear, colorless, and sterile solution.

Briviact 10 mg/ml solution for injection and infusion, 5 ml vial is packaged in a cardboard box with 10 vials.

Marketing authorisation holder and manufacturer

Marketing authorisation holder

UCB Pharma, S.A., Allée de la Recherche 60, B-1070, Brussels, Belgium.

Manufacturer

UCB Pharma, S.A., Chemin du Foriest, B-1420 Braine-l’Alleud, Belgium.

You can request more information about this medicine from the local representative of the marketing authorisation holder:

Belgium

UCB Pharma SA/NV

Tel: + 32 / (0)2 559 92 00

Lithuania

UCB Pharma Oy Finland

Tel: + 358 9 2514 4221 (Finland)

Bulgaria

??????? ????????? ???

Tel: + 359 (0) 2 962 30 49

Luxembourg

UCB Pharma SA/NV

Tel: + 32 / (0)2 559 92 00 (Belgium)

Czech Republic

UCB s.r.o.

Tel: + 420 221 773 411

Hungary

UCB Magyarország Kft.

Tel: + 36-(1) 391 0060

Denmark

UCB Nordic A/S

Tel: + 45 / 32 46 24 00

Malta

Pharmasud Ltd.

Tel: + 356 / 21 37 64 36

Germany

UCB Pharma GmbH

Tel: + 49 / (0)2173 48 4848

Netherlands

UCB Pharma B.V.

Tel: + 31 / (0)76-573 11 40

Estonia

UCB Pharma Oy Finland

Tel: + 358 9 2514 4221 (Finland)

Norway

UCB Nordic A/S

Tel: + 47 / 67 16 5880

Greece

UCB ???

Tel: + 30 / 2109974000

Austria

UCB Pharma GmbH

Tel: + 43-(0)1 291 80 00

Spain

UCB Pharma, S.A.

Tel: + 34 / 91 570 34 44

Poland

UCB Pharma Sp. z o.o. / VEDIM Sp. z o.o.

Tel: + 48 22 696 99 20

France

UCB Pharma S.A.

Tel: + 33 / (0)1 47 29 44 35

Portugal

UCB Pharma (Produtos Farmacêuticos), Lda

Tel: + 351 / 21 302 5300

Croatia

Medis Adria d.o.o.

Tel: +385 (0) 1 230 34 46

Romania

UCB Pharma Romania S.R.L.

Tel: + 40 21 300 29 04

Ireland

UCB (Pharma) Ireland Ltd.

Tel: + 353 / (0)1-46 37 395

Slovenia

Medis, d.o.o.

Tel: + 386 1 589 69 00

Iceland

Vistor hf.

Tel: + 354 535 7000

Slovakia

UCB s.r.o., organizačná zložka

Tel: + 421 (0) 2 5920 2020

Italy

UCB Pharma S.p.A.

Tel: + 39 / 02 300 791

Finland

UCB Pharma Oy Finland

Tel: + 358 9 2514 4221

Cyprus

Lifepharma (Z.A.M.) Ltd

Tel: + 357 22 05 63 00

Sweden

UCB Nordic A/S

Tel: + 46 / (0) 40 29 49 00

Latvia

UCB Pharma OÜ

Tel: + 358 9 2514 4221 (Finland)

United Kingdom

UCB (Pharma) Ireland Ltd.

Tel: + 353 / (0)1-46 37 395

Date of last revision of this leaflet:

Other sources of information

Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu

This information is intended only for healthcare professionals:

Briviact solution for injection and infusion can be administered as an intravenous bolus or as an intravenous infusion:

  • Intravenous bolus: can be administered directly without dilution
  • Intravenous infusion: can be administered over 15 minutes in a compatible diluent

Briviact can be diluted with the following solutions: sodium chloride 9 mg/ml (0.9%), glucose solution for injection 50 mg/ml (5%), or Ringer's lactate solution.

Each vial of Briviact solution for injection and infusion is for single use only. The unused solution should be discarded (see section 3).

Alternatives to BRIVIACT 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION in other countries

The best alternatives with the same active ingredient and therapeutic effect.

Alternative to BRIVIACT 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION in Poland

Dosage form: Tablets, 100 mg
Active substance: brivaracetam
Importer: PharOS MT Ltd. Pharos Pharmaceutical Oriented Services Ltd.
Prescription required
Dosage form: Tablets, 75 mg
Active substance: brivaracetam
Importer: PharOS MT Ltd. Pharos Pharmaceutical Oriented Services Ltd.
Prescription required
Dosage form: Tablets, 50 mg
Active substance: brivaracetam
Importer: PharOS MT Ltd. Pharos Pharmaceutical Oriented Services Ltd.
Prescription required
Dosage form: Tablets, 25 mg
Active substance: brivaracetam
Importer: PharOS MT Ltd. Pharos Pharmaceutical Oriented Services Ltd.
Prescription required
Dosage form: Tablets, 10 mg
Active substance: brivaracetam
Importer: PharOS MT Ltd. Pharos Pharmaceutical Oriented Services Ltd.
Prescription required

Online doctors for BRIVIACT 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION

Discuss dosage, side effects, interactions, contraindications, and prescription renewal for BRIVIACT 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION – subject to medical assessment and local rules.

0.0(1)
Doctor

Sergei Nalkin

Neurology11 years of experience

Dr. Sergei Nalkin, PhD, is a neurologist, specialising in sports medicine and rehabilitation. He provides expert care for patients with neurological, musculoskeletal, and post-traumatic conditions, focusing on functional recovery and long-term symptom relief.

Dr. Nalkin offers consultations and treatment for:

  • Neurological disorders including migraines, tension headaches, and peripheral neuropathies.
  • Rehabilitation after stroke, brain injury, and spinal cord trauma.
  • Chronic pain syndromes and musculoskeletal dysfunctions.
  • Sports-related injuries: prevention, treatment, and recovery planning.
  • Coordination and movement disorders affecting mobility and balance.
  • Custom rehabilitation programmes for neurological and orthopedic conditions.

With a personalised, evidence-based approach, Dr. Nalkin helps patients restore physical function, reduce pain, and improve quality of life through targeted therapy and long-term support.

CameraBook a video appointment
€55
November 913:00
November 913:40
November 914:20
November 915:00
November 1613:00
More times
5.0(21)
Doctor

Ekaterina Agapova

Neurology8 years of experience

Dr. Ekaterina Agapova is a neurologist specialising in the diagnosis and treatment of neurological conditions and chronic pain. She provides online consultations for adults, combining evidence-based medicine with a personalised approach.

She offers expert care for:

  • Headaches and migraines, including tension-type and cluster headaches.
  • Neck and back pain, both acute and chronic.
  • Chronic pain syndromes – fibromyalgia, neuropathic pain, post-traumatic pain.
  • Mononeuropathies – carpal tunnel syndrome, trigeminal neuralgia, facial nerve palsy.
  • Polyneuropathies – diabetic, toxic, and other types.
  • Multiple sclerosis – diagnosis, monitoring, long-term support.
  • Dizziness and coordination disorders.
  • Sleep disturbances – insomnia, daytime sleepiness, fragmented sleep.
  • Anxiety, depression, and stress-related conditions.

Dr. Agapova helps patients manage complex neurological symptoms like pain, numbness, weakness, poor sleep, and emotional distress. Her consultations focus on accurate diagnosis, clear explanation of findings, and tailored treatment plans.

If you’re struggling with chronic pain, migraines, nerve disorders, or sleep problems, Dr. Agapova offers professional guidance to restore your well-being.

CameraBook a video appointment
€49
November 1008:00
November 1008:45
November 1009:30
November 1010:15
November 1011:00
More times
5.0(49)
Doctor

Sergey Ilyasov

Psychiatry6 years of experience

Dr Sergey Ilyasov is an experienced neurologist and qualified psychiatrist who provides online consultations for adults and children worldwide. Combining deep neurological expertise with a modern psychiatric approach, he ensures comprehensive diagnostics and effective treatment for a wide range of conditions affecting both physical and mental health.

Dr. Ilyasov helps patients in the following cases:

  • Chronic headaches (migraine, tension-type headache), back pain, neuropathic pain, dizziness, numbness in limbs, coordination disorders.
  • Anxiety disorders (panic attacks, generalized anxiety disorder), depression (including atypical and treatment-resistant forms), sleep disturbances (insomnia, hypersomnia, nightmares), stress, burnout.
  • Chronic pain syndromes and psychosomatic symptoms (e.g., irritable bowel syndrome related to stress, vegetative-vascular dystonia).
  • Behavioral disorders and concentration difficulties in children and adolescents (including ADHD, autism spectrum disorders), nervous tics.
  • Memory impairments, phobias, obsessive-compulsive disorder (OCD), emotional swings, and support for post-traumatic stress disorder (PTSD).

Thanks to his dual specialization in neurology and psychiatry, Dr Sergey Ilyasov offers integrated and evidence-based care for complex conditions requiring a multidisciplinary approach. His consultations focus on accurate diagnosis, development of an individualized treatment plan (including pharmacotherapy and psychotherapeutic methods), and long-term support adapted to each patient's unique needs.

Book an online consultation with Dr. Sergey Ilyasov to receive qualified assistance and improve your well-being today.

CameraBook a video appointment
€89
November 1915:15
November 2615:15
December 315:15
December 316:10
More times

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2025 Oladoctor. All rights reserved.
VisaMastercardStripe